Scientific American [feedly], India—On a drizzly Monday afternoon here a few weeks ago, patients crowded around a door in a hallway in P. D. Hinduja Hospital—a private, nonprofit facility that caters to around 350,000 people per year. There is a loud, steady roar of voices, and patients and nurses have to shoulder past one another to get through the door, which leads to the office of lung specialist Zarir Udwadia. The walls are clean and white, and the air carries the tangy smell of disinfectant.

Against one of those white walls a grizzled old man with a breathing tube in his nose lies moaning on a stretcher. Nearby, clutching a sheaf of prescriptions, the father of a sick college student tries to catch the attention of one of Udwadia’s assisting physicians. Several families have traveled thousands of kilometers to be here. Many of these patients, like 19-year-old Nisha, an engineering student from the central state of Madhya Pradesh, have tuberculosis (TB). Nisha, who asked that her real name be withheld, has been treated for lung problems for more than a year, only to learn that inaccurate diagnoses and prescription errors have supercharged the disease rather than curing it. “My doctors kept on changing the drugs,” says Nisha. Dressed in jeans and a floral-print blouse and black Buddy Holly–style horn-rimmed glasses, she speaks in a bright, optimistic voice, although her battle with TB has left her anorexic-thin.

By exposing Nisha’s TB to various drugs without wiping it out, her doctors just made it stronger, a problem that Udwadia—the doctor who first identified extreme drug resistance in the germ—and other health experts say is becoming increasingly widespread in India. Too few diagnostic laboratories, too many poorly-trained health practitioners and thousands of infected people living in crowded, unsanitary conditions has made India home to the world’s largest epidemic of drug-resistant TB. More than two million Indians every year get the highly contagious disease, and a patient dies every two minutes. Around 62,000 of these people harbor TB that is immune to at least four types of drugs, according to the World Health Organization, and as many as 15,000 may have an even more dangerous type called “extensively drug-resistant” TB that fights off almost every antibiotic in the medical arsenal.

Now, difficult-to-kill TB is no longer just India’s nightmare. In June U.S. health authorities confirmed that an Indian patient carried this extreme form of the infection, called XDR-TB, across the ocean to Chicago. The patient drove from there to visit relatives as far away as Tennessee and Missouri. Health officials in several states are tracking down everyone with whom the patient—who is now quarantined and being treated at the National Institutes of Health in Maryland—had prolonged contact. The disease can be cured in only 30 percent of patients and sometimes requires surgery to remove infected parts of lungs. Although TB’s slow rate of infection makes explosive epidemics unlikely, the Chicago episode shows how easy it might be for the illness to become a worldwide export.

Please continue reading from: 
http://www.scientificamerican.com/article/supercharged-tuberculosis-made-in-india1/

DISCLAIMER: Environmental, Health and Safety News is not affiliated with or maintained by ANY for profit or non-profit entity. It is a 100% volunteer effort free from advertising or sponsorship of any kind. This site is intended to be an educational and not-for-profit website providing useful information for security, environmental, health, sciences, transportation, and public safety professionals and the general public. It is not “for the purpose of trade, to induce the sale of any goods or services.”
In the Webmaster’s opinion, any incidental use of any pictures and graphics, or quoted words on this site is not a violation of any trademark for the any reasons stated above. The webmaster will fully cooperate with any and everyone that believes any section of the site are in violation of fair use.

The use of any and all copyrighted works in the creation of this site is, in the Webmaster’s opinion, protected by 17 USC 107 (see Creative Commons License below). If the owner of a copyrighted work used in the creation of this site believes that 17 USC 107 does not apply to the use of their work, the site’s creator will cooperate to the fullest extent possible.

FAIR USE NOTE: The site provides information of a general & public nature regarding national or other developments. None of the information contained herein is intended as legal advice or opinions relative to specific matters, facts, situations or issues. Additional facts, information or future developments may affect the subjects addressed in this site. You should consult with an expert about your particular circumstances before acting on any of this information because it may not be applicable to your situation. This site contains information and links to sites which are not owned or maintained by this site. This site is not responsible for the content, linked sites, and the views expressed on linked sites do not necessarily reflect our views or opinions. The information contained herein is provided for personal, non-commercial, educational, entertainment and informational purposes only and does not constitute a guarantee of information or facts. This site makes no claims, expressed, implied, or statutory regarding the accuracy, timeliness, completeness, or correctness of any material contained herein. Since the conditions of use are outside my control, the individual visitor is entirely responsible for determining the appropriateness and applicability of all information contained herein.

This website is licensed under a Creative Commons License.

Back to Top